On January 5, 2022 Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, adjuvants, and vaccines designed to activate immune response to cancers and infections, reported that management will participate in the following upcoming investor conferences (Press release, Agenus, JAN 5, 2022, View Source [SID1234598265]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
H.C. Wainwright Bioconnect Conference – presentation will be available on-demand from Monday, January 10, 2022 from 7:00 AM EST
B. Riley Securities’ 2022 Virtual Oncology Conference – presentation will be on Thursday, January 27, 2022 at 1:00 PM EST
A webcast/replay for the conferences may be accessed on the company’s website at View Source